Biographical Sketch
Donald A. Malone, Jr., MD, is currently a Staff Psychiatrist at Cleveland Clinic. He also performs duties as Section Head of Adult Primary Psychiatric Services and Director of the Psychiatric Neuromodulation Center.
Dr. Malone graduated with his MD degree from Northeastern Ohio University?s College of Medicine in 1985. There he was a member of Alpha Omega Alpha. Following his medical school training, he did one year of internship in internal medicine followed by a psychiatric residency at Massachusetts General Hospital. He was Chief Resident of the acute psychiatry service at Massachusetts General during his final year. Since 1989, he has been at Cleveland Clinic.
Dr. Malone has been very active in research, education and various local and national committees. He has held positions in the Ohio Psychiatric Association, American Psychiatric Association, the Association for Convulsive Therapy, and American College of Psychiatrists. He is Past-President and on the Board of Directors of the Association for Convulsive Therapy.
His research has been primarily in the areas of anxiety disorders, anabolic steroid use and abuse, ECT and, most recently, deep-brain stimulation. He has authored a number of publications in these areas and presented both nationally and internationally. His current research focuses primarily on the use of deep-brain stimulation in psychiatric disorders.
Specialty Interests
adult psychoparmacology, anxiety and mood disorders, anxiety disorders, depressive disorders, mood and anxiety disorders, mood disorders, OCD, Panic Disorder, Psychopharmacology, sports psychiatry, VNS and DBS
Innovations & Patents
Involved with pioneering developments in the use of deep-brain stimulation for highly refractory patients with obsessive-compulsive disorder and major depression
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 7/30/2008, Dr.
Malone has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Malone receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Bristol-Myers Squibb Company
Eli Lilly and Company
Jazz Pharmaceuticals
